Medical device regulators at the Food and Drug Administration have updated guidance clarifying what Least Burdensome Provisions mean for US market registrants.
Get the full story here at the Emergo Group’s blog.
The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.
The post FDA refines least burdensome guidance for medical device oversight appeared first on MassDevice.
from MassDevice http://ift.tt/2qd9lL9
Cap comentari:
Publica un comentari a l'entrada